309 related articles for article (PubMed ID: 11526485)
1. Genetic mapping and DNA sequence-based analysis of deleted regions on chromosome 16 involved in progression of bladder cancer from occult preneoplastic conditions to invasive disease.
Yoon DS; Li L; Zhang RD; Kram A; Ro JY; Johnston D; Grossman HB; Scherer S; Czerniak B
Oncogene; 2001 Aug; 20(36):5005-14. PubMed ID: 11526485
[TBL] [Abstract][Full Text] [Related]
2. Genetic modeling of human urinary bladder carcinogenesis.
Czerniak B; Li L; Chaturvedi V; Ro JY; Johnston DA; Hodges S; Benedict WF
Genes Chromosomes Cancer; 2000 Apr; 27(4):392-402. PubMed ID: 10719370
[TBL] [Abstract][Full Text] [Related]
3. Superimposed histologic and genetic mapping of chromosome 9 in progression of human urinary bladder neoplasia: implications for a genetic model of multistep urothelial carcinogenesis and early detection of urinary bladder cancer.
Czerniak B; Chaturvedi V; Li L; Hodges S; Johnston D; Roy JY; Luthra R; Logothetis C; Von Eschenbach AC; Grossman HB; Benedict WF; Batsakis JG
Oncogene; 1999 Feb; 18(5):1185-96. PubMed ID: 10022124
[TBL] [Abstract][Full Text] [Related]
4. Superimposed histologic and genetic mapping of chromosome 17 alterations in human urinary bladder neoplasia.
Chaturvedi V; Li L; Hodges S; Johnston D; Ro JY; Logothetis C; von Eschenbach AC; Batsakis JG; Czerniak B
Oncogene; 1997 May; 14(17):2059-70. PubMed ID: 9160886
[TBL] [Abstract][Full Text] [Related]
5. Evidence for two tumor suppressor loci associated with proximal chromosome 9p to q and distal chromosome 9q in bladder cancer and the initial screening for GAS1 and PTC mutations.
Simoneau AR; Spruck CH; Gonzalez-Zulueta M; Gonzalgo ML; Chan MF; Tsai YC; Dean M; Steven K; Horn T; Jones PA
Cancer Res; 1996 Nov; 56(21):5039-43. PubMed ID: 8895761
[TBL] [Abstract][Full Text] [Related]
6. High resolution chromosome 3p allelotyping of human lung cancer and preneoplastic/preinvasive bronchial epithelium reveals multiple, discontinuous sites of 3p allele loss and three regions of frequent breakpoints.
Wistuba II; Behrens C; Virmani AK; Mele G; Milchgrub S; Girard L; Fondon JW; Garner HR; McKay B; Latif F; Lerman MI; Lam S; Gazdar AF; Minna JD
Cancer Res; 2000 Apr; 60(7):1949-60. PubMed ID: 10766185
[TBL] [Abstract][Full Text] [Related]
7. Fluorescence in situ hybridization deletion mapping at 4p16.3 in bladder cancer cell lines refines the localisation of the critical interval to 30 kb.
Bell SM; Zuo J; Myers RM; Knowles MA
Genes Chromosomes Cancer; 1996 Oct; 17(2):108-17. PubMed ID: 8913728
[TBL] [Abstract][Full Text] [Related]
8. Improved clonality analysis of multifocal bladder tumors by combination of histopathologic organ mapping, loss of heterozygosity, fluorescence in situ hybridization, and p53 analyses.
Denzinger S; Mohren K; Knuechel R; Wild PJ; Burger M; Wieland WF; Hartmann A; Stoehr R
Hum Pathol; 2006 Feb; 37(2):143-51. PubMed ID: 16426913
[TBL] [Abstract][Full Text] [Related]
9. Mapping and genome sequence analysis of chromosome 5 regions involved in bladder cancer progression.
Kram A; Li L; Zhang RD; Yoon DS; Ro JY; Johnston D; Grossman HB; Scherer S; Czerniak B
Lab Invest; 2001 Jul; 81(7):1039-48. PubMed ID: 11454992
[TBL] [Abstract][Full Text] [Related]
10. Novel suppressor loci on chromosome 14q in primary bladder cancer.
Chang WY; Cairns P; Schoenberg MP; Polascik TJ; Sidransky D
Cancer Res; 1995 Aug; 55(15):3246-9. PubMed ID: 7614456
[TBL] [Abstract][Full Text] [Related]
11. Genome-wide amplification and allelotyping of sporadic pituitary adenomas identify novel regions of genetic loss.
Simpson DJ; Bicknell EJ; Buch HN; Cutty SJ; Clayton RN; Farrell WE
Genes Chromosomes Cancer; 2003 Jul; 37(3):225-36. PubMed ID: 12759921
[TBL] [Abstract][Full Text] [Related]
12. Loss of heterozygosity at chromosome 16q in prostate adenocarcinoma: identification of three independent regions.
Latil A; Cussenot O; Fournier G; Driouch K; Lidereau R
Cancer Res; 1997 Mar; 57(6):1058-62. PubMed ID: 9067271
[TBL] [Abstract][Full Text] [Related]
13. Four tumor suppressor loci on chromosome 9q in bladder cancer: evidence for two novel candidate regions at 9q22.3 and 9q31.
Simoneau M; Aboulkassim TO; LaRue H; Rousseau F; Fradet Y
Oncogene; 1999 Jan; 18(1):157-63. PubMed ID: 9926930
[TBL] [Abstract][Full Text] [Related]
14. Loss of heterozygosity analysis and DNA copy number measurement on 8p in bladder cancer reveals two mechanisms of allelic loss.
Adams J; Williams SV; Aveyard JS; Knowles MA
Cancer Res; 2005 Jan; 65(1):66-75. PubMed ID: 15665280
[TBL] [Abstract][Full Text] [Related]
15. Identification of loci associated with putative recurrence genes in transitional cell carcinoma of the urinary bladder.
Edwards J; Duncan P; Going JJ; Watters AD; Grigor KM; Bartlett JM
J Pathol; 2002 Apr; 196(4):380-5. PubMed ID: 11920732
[TBL] [Abstract][Full Text] [Related]
16. Three distinct commonly deleted regions of chromosome arm 16q in human primary and metastatic prostate cancers.
Suzuki H; Komiya A; Emi M; Kuramochi H; Shiraishi T; Yatani R; Shimazaki J
Genes Chromosomes Cancer; 1996 Dec; 17(4):225-33. PubMed ID: 8946204
[TBL] [Abstract][Full Text] [Related]
17. Allelotype analysis of 2',3'-dideoxycytidine- and 1,3-butadiene-induced lymphomas in B6C3F1 mice.
Zhuang SM; Eklund LK; Cochran C; Rao GN; Wiseman RW; Söderkvist P
Cancer Res; 1996 Jul; 56(14):3338-43. PubMed ID: 8764131
[TBL] [Abstract][Full Text] [Related]
18. An 800-kb region of deletion at 13q14 in human prostate and other carcinomas.
Chen C; Frierson HF; Haggerty PF; Theodorescu D; Gregory CW; Dong JT
Genomics; 2001 Oct; 77(3):135-44. PubMed ID: 11597138
[TBL] [Abstract][Full Text] [Related]
19. Distinct regions of allelic loss on chromosome 4 in human primary bladder carcinoma.
Polascik TJ; Cairns P; Chang WY; Schoenberg MP; Sidransky D
Cancer Res; 1995 Nov; 55(22):5396-9. PubMed ID: 7585608
[TBL] [Abstract][Full Text] [Related]
20. [Loss of heterozygosity fine mapping of chromosome 17p13 in transitional cell carcinoma of human urinary bladder].
Zheng S; Zhang J; Di X; Xiao Z; Wang D; Li C; He Z; Han N; Guo S; Cheng S; Gao Y
Zhonghua Yi Xue Za Zhi; 2002 Feb; 82(3):161-3. PubMed ID: 11953150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
